PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression

To overcome cancer cells resistance to pharmacological therapy, the development of new therapeutic approaches becomes urgent. For this purpose, the use of poly(ADP-ribose) polymerase (PARP) inhibitors in combination with other cytotoxic agents could represent an efficacious strategy. Poly(ADP-ribosy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Mariano, Germano, Ricciardi, Maria Rosaria, Trisciuoglio, Daniela, Zampieri, Michele, Ciccarone, Fabio, Guastafierro, Tiziana, Calabrese, Roberta, Valentini, Elisabetta, Tafuri, Agostino, Del Bufalo, Donatella, Caiafa, Paola, Reale, Anna
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2015
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558132/
https://ncbi.nlm.nih.gov/pubmed/25938539
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы